腾讯AI持续发展，科创100ETF华夏（588800）盘中再创新高

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index decreased by 0.11% as of July 18, 2025, with mixed performance among constituent stocks [1] - Rongchang Biotechnology led the gains with an increase of 6.84%, while Sanofi Biopharma experienced the largest decline at 3.71% [1] - The Huaxia Sci-Tech 100 ETF (588800) fell by 0.10% but reached a new intraday high, with a turnover rate of 1.42% and a transaction volume of 41.85 million yuan [1] Group 2 - Huatai Securities predicts that breakthroughs in artificial intelligence (AI) technology will impact the entire industry chain, highlighting the importance of computing power, data, and energy as foundational resources [2] - The report outlines a four-part development path for AI: upstream focus on computing power, midstream innovations in algorithms, downstream rapid expansion of applications, and attention to ethical and geopolitical issues arising from AI development [2] - The Huaxia Sci-Tech 100 ETF closely tracks the Sci-Tech 100 Index, which is the first and only mid-cap style index on the Sci-Tech Board, focusing on high-growth sectors such as pharmaceuticals and new energy [2]